Volgende

Automatisch afspelen

The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma

2 Bekeken • 07/18/23
Delen
insluiten
administrator
administrator
abonnees
0

Symantha Melemed, PhD, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the FDA approval of olaratumab (Lartruvo) and its long-term potential in the field of sarcoma.

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen